Pharmaceutical Industry and FDA Use Mob Tactics to Silence Whistleblowers
Peter Gøtzsche argues that we should consider allowing whistleblowers to publish anonymously for their safety.
Source: madinamerica.com
Stay updated with breaking news from Eter Gøtzsche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peter Gøtzsche argues that we should consider allowing whistleblowers to publish anonymously for their safety.
Clinical trials also consistently fail to measure and report long-term harmful effects.